Cambiotics ApS
Private limited companyCVR 44572370København NActive
Cambiotics ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2024. Equity was negative at the end of 2025 (−DKK 5.6m). The company is new and has been registered for 2 years. The latest net result (2025) was a loss of DKK 5.7m.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesEmployees
- 2 more employees than a year earlier: 7 (07/2026) against 5 (07/2025).
Management and owners, last 24 months
- New in management: Steen Dannemann Andersen (chair of the board, 11/04/2025), Kiran Raosaheb Patil (board member, 11/04/2025) and Matthew Gabriel Kaufman (board member, 21/01/2026).
- Stepped down: Kiran Raosaheb Patil (chair of the board, 10/04/2025).
- New owners registered: Anna Elisabeth Lindell (21/01/2026), Artefakt Holding ApS (21/01/2026) and Danmarks Eksport- og Investeringsfond (21/01/2026) (+7).
- No longer registered as owner: Torsten Høybye Bak Regueira (29/11/2024), Anna Elisabeth Lindell (20/01/2026) and Artefakt Holding ApS (28/11/2024) (+6).
Registrations, last 24 months
- 21/01/2026: Share capital changed from 42,105 DKK to 63,029 DKK
- 11/04/2025: Share capital changed from 40,000 DKK to 42,105 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | −3,272 | – |
| Operating profit (EBIT) | −5,986 | – |
| Profit before tax | −6,357 | – |
| Net profit | −5,679 | – |
| Total assets | 5,475 | – |
| Equity | −5,637 | – |
| Liabilities | 11,112 | – |
| Cash and cash equivalents | 4,714 | – |
| Average number of employees | 3 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 5.6m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 18/01/2024 – 30/06/2025 | 14/11/2025 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,393of 69,742 Better than 1% | No. 69,256of 69,964 Better than 1% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 283of 323 Better than 12% | No. 290of 329 Better than 12% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,500of 16,614 Better than 1% | No. 16,516of 16,661 Better than 1% |
| All companies of type ApS66,508 companies in the comparison | No. 66,085of 66,379 Better than 0% | No. 65,803of 66,505 Better than 1% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Cambiotics ApS−DKK 3.3m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Cambiotics ApS−DKK 5.7m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Cambiotics ApS−DKK 5.6m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Cambiotics ApS7
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Anna Elisabeth Lindell10%
- Artefakt Holding ApS25%
- Danmarks Eksport- og Investeringsfond5%
- Kiran Raosaheb Patil10%
- Collab VI, L.P.10%
- True Capital Growth Iii LP5%
- BII Holdings A/S10%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Peter Holme Jensen | CEO | 18/01/2024 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Peter Holme Jensen | Board member | 14/02/2024 |
| Steen Dannemann Andersen | Chair of the board | 11/04/2025 |
| Kiran Raosaheb Patil | Board member | 11/04/2025 |
| Matthew Gabriel Kaufman | Board member | 21/01/2026 |
- Founders
- Torsten Høybye Bak Regueira, Artefakt Holding ApS, Kiran Raosaheb Patil, Anna Elisabeth Lindell, James Emanuel Dharendra Thaventhiran
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Torsten Høybye Bak Regueira | Board member | 18/01/2024 | 02/02/2024 |
| Kiran Raosaheb Patil | Chair of the board | 18/01/2024 | 10/04/2025 |
Signing rule: Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af en direktør i forening med et andet bestyrelsesmedlem.
Address and production units
1 active production unitsOle Maaløes Vej 3
2200 København N
København Municipality · Postcode 2200
Other companies at the address (8)
- BII Holdings A/SOther financial service activities n.e.c.
- Skape Bio ApSResearch and experimental development on natural sciences and engineering
- Agrobiomics ApSResearch and experimental development on natural sciences and engineering
- Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
- BioColor ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Cambiotics ApS | Ole Maaløes Vej 3, 2200 København N | 7 | 1030015394 |
Purpose
Selskabets formål er forskning i, udvikling af, og kommercialisering af probiotiske og relaterede produkter for at forbedre sundhed.
The purpose is quoted from the register in Danish.
Changes year by year
38 registered events202614 changesownership 12 · capital 1 · management 1
- OwnershipBII Holdings A/S registered as owner (10%)
- OwnershipBioInnovation Institute Fonden is no longer registered as owner
- CapitalShare capital changed from 42,105 DKK to 63,029 DKK
- ManagementMatthew Gabriel Kaufman appointed board member
- OwnershipBioInnovation Institute Fonden registered as owner (10%)
- OwnershipAnna Elisabeth Lindell registered as owner (10%)
- OwnershipARTEFAKT HOLDING ApS registered as owner (25%)
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (5%)
- OwnershipKiran Raosaheb Patil registered as owner (10%)
- OwnershipCollab VI, L.P. registered as owner (10%)
- OwnershipTRUE CAPITAL GROWTH III LP registered as owner (5%)
- OwnershipARTEFAKT HOLDING ApS is no longer registered as owner
- OwnershipKiran Raosaheb Patil is no longer registered as owner
- OwnershipAnna Elisabeth Lindell is no longer registered as owner
20259 changesaccounts 1 · capital 1 · management 3 · ownership 3 · industry 1
- AccountsAnnual report for 2025 published
- CapitalShare capital changed from 40,000 DKK to 42,105 DKK
- ManagementSteen Dannemann Andersen appointed chair of the board
- ManagementKiran Raosaheb Patil appointed board member
- OwnershipARTEFAKT HOLDING ApS registered as owner (33.33%)
- OwnershipAnna Elisabeth Lindell is no longer registered as owner
- ManagementKiran Raosaheb Patil stepped down as chair of the board
- OwnershipARTEFAKT HOLDING ApS is no longer registered as owner
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202415 changesownership 9 · management 5 · founded 1
- OwnershipARTEFAKT HOLDING ApS registered as owner (50%)
- OwnershipTorsten Høybye Bak Regueira is no longer registered as owner
- OwnershipJames Emanuel Dharendra Thaventhiran is no longer registered as owner
- OwnershipARTEFAKT HOLDING ApS is no longer registered as owner
- ManagementPeter Holme Jensen appointed board member
- ManagementTorsten Høybye Bak Regueira stepped down as board member
- FoundedRegistered as Cambiotics ApS
- ManagementTorsten Høybye Bak Regueira appointed board member
- ManagementPeter Holme Jensen appointed ceo
- ManagementKiran Raosaheb Patil appointed chair of the board
- OwnershipARTEFAKT HOLDING ApS registered as owner (20%)
- OwnershipKiran Raosaheb Patil registered as owner (20%)
- OwnershipTorsten Høybye Bak Regueira registered as owner (20%)
- OwnershipJames Emanuel Dharendra Thaventhiran registered as owner (20%)
- OwnershipAnna Elisabeth Lindell registered as owner (20%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- ADM Denmark A/Svia Steen Dannemann Andersen
- Probiotix Health Denmark ApSvia Steen Dannemann Andersen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.